Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Chemical and Drug Induced Liver Injury

Known as: Chemical and Drug Induced Liver Injury [Disease/Finding] 
A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal… Expand
National Institutes of Health

Related topics

Related topics

11 relations

Narrower (6)

Chemically-Induced Liver ToxicityDrug-Induced Liver DiseaseHalothane HepatitisHepatitis, Drug-Induced
Expand
In BloodMicrobiologicalnursing therapyprevention & control
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death worldwide. Risk factors for HCC include… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2019
Review
2019
Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges.
Chronic infection with hepatitis C virus is a major cause of liver disease and hepatocellular carcinoma worldwide. After the… Expand
Is this relevant?
Review
2019
Review
2019
Autophagy in liver diseases: Time for translation?
Autophagy is a self-eating catabolic pathway that contributes to liver homeostasis through its role in energy balance and in the… Expand
Is this relevant?
Review
2019
Review
2019
Serum Hepatitis B Virus RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection
Chronic hepatitis B infection is one of the major etiological causes of liver failure, cirrhosis, and hepatocellular carcinoma… Expand
Is this relevant?
Review
2019
Review
2019
Inflammatory pathways in alcoholic steatohepatitis.
Inflammatory processes are primary contributors to the development and progression of alcoholic steatohepatitis (ASH), with… Expand
Is this relevant?
Review
2019
Review
2019
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial.
BACKGROUND There is no recommended therapy for malignant pleural mesothelioma that has progressed after first-line pemetrexed and… Expand
Is this relevant?
Review
2018
Review
2018
miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis
Nonalcoholic fatty liver disease (NAFLD) defines a wide pathological spectrum ranging from simple steatosis to nonalcoholic… Expand
  • figure 1
  • table 1
Is this relevant?
Review
2018
Review
2018
Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression
Liver fibrosis occurs in response to different etiologies of chronic liver injury. Diagnosing degree of liver fibrosis is a… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Review
2018
Review
2018
Liver sinusoidal endothelial cells — gatekeepers of hepatic immunity
Liver sinusoidal endothelial cells (LSECs) line the low shear, sinusoidal capillary channels of the liver and are the most… Expand
  • table 1
Is this relevant?
Review
2018
Review
2018
Resveratrol: A Double-Edged Sword in Health Benefits
Resveratrol (3,5,4′-trihydroxy-trans-stilbene) belongs to polyphenols’ stilbenoids group, possessing two phenol rings linked to… Expand
  • figure 1
  • figure 2
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE